NCT07751133
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07751133
Title Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer (ENHANCE)
Acronym ENHANCE
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR


No variant requirements are available.